Salivary Cortisol is Associated with Diagnosis and Severity of Late-life Generalized Anxiety Disorder

Overview

Journal Psychoneuroendocrinology

Specialties Endocrinology
Neurology
Psychiatry

Date 2008 Apr 15

PMID 18407426

Citations 70

Authors

Rose C Mantella

Meryl A Butters

Janet A Amico

Sati Mazumdar

Bruce L Rollman

Amy E Begley

Charles F Reynolds

Eric J Lenze

Affiliations

Soon will be listed here.

Abstract

Age-associated alterations in hypothalamic-pituitary-adrenal (HPA) axis functioning may make individuals more susceptible to HPA dysregulation in the context of mood and anxiety disorders. Little to no research has been done to examine HPA axis function in generalized anxiety disorder (GAD), particularly in late-life GAD, the most prevalent anxiety disorder in the elderly. The study sample consisted of 71 GAD subjects and 40 nonanxious comparison subjects over 60 years of age. We examined the hypotheses that elderly individuals with GAD will have elevated salivary cortisol levels compared to nonanxious subjects, and that elevated cortisol levels in GAD will be associated with measures of symptom severity. We report that late-life GAD is characterized by elevated basal salivary cortisol levels, with higher peak cortisol levels and larger areas under the curve, compared to nonanxious subjects. Additionally, severity of GAD as measured by the GAD Severity Scale and the Penn State Worry Questionnaire are positively correlated with cortisol levels. These data demonstrate HPA axis dysfunction in late-life GAD and suggest the need for additional research on the influence of aging on HPA axis function in mood and anxiety disorders.

Citing Articles

Adding salt to foods and risk of incident depression and anxiety.

Wang W, Chang X, Lin F, Feng L, Wang M, Huang J BMC Med. 2025; 23(1):32.

PMID: 39838382 PMC: 11752635. DOI: 10.1186/s12916-025-03865-x.

Increasing stress resilience in older adults through a 6-week prevention program: effects on coping strategies, anxiety symptoms, and cortisol levels.

Richer M, Grenier S, Lupien S, Plusquellec P Front Psychol. 2025; 15():1499609.

PMID: 39834757 PMC: 11743716. DOI: 10.3389/fpsyg.2024.1499609.

Increased serum EGF but not SDF-1 levels are associated with the pathophysiology and development of generalized anxiety disorder.

Roknuzzaman A, Qusar M, Shahriar M, Islam S, Islam M Sci Rep. 2024; 14(1):27409.

PMID: 39521929 PMC: 11550425. DOI: 10.1038/s41598-024-79166-9.

A comparative study on hair cortisol concentration among generalized anxiety disorder patients with and without alcohol dependence syndrome presenting to a tertiary care center: A pilot study.

Bijjal S, Huchegowda R, Gowda S, Harbishettar V, Deshpande S, Sharma M Indian J Psychiatry. 2024; 66(9):838-845.

PMID: 39502600 PMC: 11534134. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_520_24.

Shoden promotes Relief from stress and anxiety: A randomized, double-blind, placebo-controlled study on healthy subjects with high stress levels.

Mishra D, Kumar M Heliyon. 2024; 10(17):e36885.

PMID: 39286132 PMC: 11402924. DOI: 10.1016/j.heliyon.2024.e36885.

References

Tafet G, Feder D, Abulafia D, Roffman S . Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder. Cogn Affect Behav Neurosci. 2005; 5(1):37-40. DOI: 10.3758/cabn.5.1.37. View

Wessa M, Rohleder N, Kirschbaum C, Flor H . Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology. 2005; 31(2):209-15. DOI: 10.1016/j.psyneuen.2005.06.010. View

Abelson J, Curtis G . Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry. 1996; 53(4):323-31. DOI: 10.1001/archpsyc.1996.01830040059010. View

Belanoff J, Rothschild A, Cassidy F, DeBattista C, Baulieu E, Schold C . An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry. 2002; 52(5):386-92. DOI: 10.1016/s0006-3223(02)01432-4. View

Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4):278-96. DOI: 10.1111/j.2044-8260.1967.tb00530.x. View

Kudielka B, Kirschbaum C . Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology. 2002; 28(1):35-47. DOI: 10.1016/s0306-4530(02)00008-2. View

Yehuda R . Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann N Y Acad Sci. 2006; 1071:137-66. DOI: 10.1196/annals.1364.012. View

Baker D, West S, NICHOLSON W, Ekhator N, Kasckow J, Hill K . Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999; 156(4):585-8. DOI: 10.1176/ajp.156.4.585. View

Backhaus J, Junghanns K, Hohagen F . Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology. 2004; 29(9):1184-91. DOI: 10.1016/j.psyneuen.2004.01.010. View

10.

Ising M, Kunzel H, Binder E, Nickel T, Modell S, Holsboer F . The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29(6):1085-93. DOI: 10.1016/j.pnpbp.2005.03.014. View

11.

Bliwise D . Sleep in normal aging and dementia. Sleep. 1993; 16(1):40-81. DOI: 10.1093/sleep/16.1.40. View

12.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

13.

Altemus M, Cloitre M, Dhabhar F . Enhanced cellular immune response in women with PTSD related to childhood abuse. Am J Psychiatry. 2003; 160(9):1705-7. DOI: 10.1176/appi.ajp.160.9.1705. View

14.

Bachmann C, Linthorst A, Holsboer F, Reul J . Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis. Neuropsychopharmacology. 2003; 28(6):1056-67. DOI: 10.1038/sj.npp.1300158. View

15.

Young E, Abelson J, Cameron O . Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry. 2004; 56(2):113-20. DOI: 10.1016/j.biopsych.2004.03.017. View

16.

Van Coevorden A, Mockel J, Laurent E, Kerkhofs M, LHermite-Baleriaux M, Decoster C . Neuroendocrine rhythms and sleep in aging men. Am J Physiol. 1991; 260(4 Pt 1):E651-61. DOI: 10.1152/ajpendo.1991.260.4.E651. View

17.

Van Cauter E, Leproult R, Kupfer D . Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996; 81(7):2468-73. DOI: 10.1210/jcem.81.7.8675562. View

18.

Zobel A, Nickel T, Kunzel H, Ackl N, Sonntag A, Ising M . Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res. 2000; 34(3):171-81. DOI: 10.1016/s0022-3956(00)00016-9. View

19.

Meyer T, Miller M, Metzger R, Borkovec T . Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990; 28(6):487-95. DOI: 10.1016/0005-7967(90)90135-6. View

20.

Carskadon M, Brown E, Dement W . Sleep fragmentation in the elderly: relationship to daytime sleep tendency. Neurobiol Aging. 1982; 3(4):321-7. DOI: 10.1016/0197-4580(82)90020-3. View